Clinical trial
Safety and Efficacy of Canakinumab Prefilled Syringes in Frequently Flaring…
NCT01356602 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT01356602 |
|---|---|
| Title | Safety and Efficacy of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients |
| Official title | A Randomized, Double-blind, Active-controlled Study of Canakinumab Prefilled Syringes or Reconstituted Lyophilizate Versus Triamcinolone Acetonide for Treating Acute Gouty Arthritis Flares in Frequently Flaring Patients |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acute Gouty Arthritis |
| Intervention type | Drug |
| Interventions | Canakinumab pre-filled syringe, Canakinumab lyophilized powder, Triamcinolone Acetonide, Placebo |
| Enrollment | 397 |
| Start date | May 1, 2011 |
| Primary completion | Sep 1, 2012 |
| Completion | Sep 1, 2012 |
| First posted | May 19, 2011 |
| Last update posted | Jan 29, 2014 |
| Countries | Canada, Germany, Hungary, Lithuania, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: